SEC Filing Summary: Safety Shot, Inc. (SHOT)
Business Context and Reporting Period
This Form 8-K Current Report was filed on December 20, 2024, covering events occurring on December 16, 2024. The registrant is Safety Shot, Inc., a Delaware corporation trading on the Nasdaq Capital Market under the symbol "SHOT" (common stock) and "SHOTW" (warrants). The filing primarily discloses the entry into material definitive employment agreements with three new executive officers.
Key Financial Metrics
The filing text does not provide current revenue, profit, cash flow, margins, debt, or liquidity figures. This report focuses exclusively on executive compensation structures and equity grants rather than operational financial performance.
Material Changes and Executive Appointments
On December 16, 2024, the Company appointed three new executives and entered into employment agreements with the following terms:
- John Gulyas: Appointed Executive Chairman.
- Jordon Schur: Appointed President.
- Jarrett Boon: Appointed Chief Executive Officer.
Compensation Structure (Identical for all three executives):
- Base Salary: $300,000 annually, paid bi-monthly.
- Initial Equity Grant: 1,000,000 shares of common stock (restricted), fully vested immediately.
- Performance Incentives (2025):
- H1 2025 Target: If combined Q1 and Q2 revenue reaches $500,000, the executive receives a $100,000 cash bonus and 500,000 restricted shares.
- H2 2025 Target: If combined Q3 and Q4 revenue reaches $1,000,000, the executive receives a $100,000 cash bonus and 500,000 restricted shares.
Guidance, Outlook, and Risks
The filing establishes specific revenue milestones for 2025 as conditions for executive bonuses, implying a management focus on achieving $500,000 in revenue for the first half of 2025 and $1,000,000 for the second half. The Company is designated as an emerging growth company. No other risks, contingencies, or unusual items are disclosed in this specific filing.
Investor Verification Checklist
- Verify the total number of authorized shares and the percentage of outstanding shares represented by the 3,000,000 shares immediately vested to the new executives.
- Confirm the Company's current cash position to assess its ability to fund the $900,000 in annual base salaries and potential $600,000 in performance bonuses.
- Review the full text of Exhibits 10.1, 10.2, and 10.3 for termination clauses, non-compete provisions, and clawback policies not summarized in the 8-K.
- Assess the feasibility of the 2025 revenue targets ($500k H1, $1M H2) relative to the Company's historical performance and current market conditions.